FAIM
GSK icon

Financial Advocates Investment Management’s GSK GSK Stock Holding History

Financial Advocates Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,803
Closed -$206K – 729
2023
Q1 		$206K Buy
+5,803
New +$203K 0.01% 680
2022
Q4 		– Sell
-27,563
Closed -$3.2M – 808
2022
Q3 		$3.2M Buy
+27,563
New +$1.04M 0.26% 101
2022
Q2 		– Sell
-4,137
Closed -$225K – 727
2022
Q1 		$225K Sell
4,137
-227
-5% -$12.3K 0.01% 659
2021
Q4 		$240K Buy
4,364
+2,092
+92% +$109K 0.02% 681
2021
Q3 		$222K Buy
+2,272
New +$114K 0.02% 681

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Financial Advocates Investment Management's GSK Position: Q2 2023 in Review

Financial Advocates Investment Management sold out of GSK (GSK) in Q2 2023, closing a stake of 5,803 shares — an estimated $206K sold.

Financial Advocates Investment Management first reported a position in GSK in Q3 2021 and held it in 5 quarters. The position peaked at $3.2M in Q3 2022. 828 funds tracked by Wall St. Rank hold GSK as of Q2 2023.

  • Financial Advocates Investment Management reported no remaining GSK position as of Q2 2023 after selling out during the quarter.
  • Financial Advocates Investment Management sold 5,803 GSK shares in Q2 2023, an estimated $206K.
  • Financial Advocates Investment Management first reported a position in GSK in Q3 2021 and held it in 5 quarters.
  • Financial Advocates Investment Management's GSK position peaked at $3.2M in Q3 2022.
  • 828 funds tracked by Wall St. Rank held GSK as of Q2 2023.

Based on Financial Advocates Investment Management's 13F filing for Q2 2023, filed 7 Aug 2023.